-
A Peek Into The Market Before The Trading Starts
Friday, April 29, 2011 - 7:34am | 379Pre-open movers US stock futures are slightly higher this morning as investors are awaiting economic reports and corporate results. Futures on the Dow Jones Industrial Average gained 10 points to 12,718.00 and S&P 500 index futures rose 1 point to 1,355.90. Futures on the Nasdaq 100 rose 2.75...
-
UPDATE: Merck Reports Upbeat Q1 Earnings; Shares Rise In Pre-Market trading
Friday, April 29, 2011 - 7:28am | 117Merck & Co (NYSE: MRK) reported a more than three-fold surge in its Q1 net income. The company's quarterly net income increased to $1.04 billion, or $0.34 per share, from $299 million, or $0.09 per share, in the year-earlier period. The company's sales increased 1% to $11.58 billion from $11....
-
Merck Announces First Quarter 2011 Financial Results
Friday, April 29, 2011 - 7:09am | 74Merck (NYSE: MRK) today announced financial results for the first quarter of 2011. Double-Digit EPS Growth in First Quarter 2011: Non-GAAP EPS of $0.92; GAAP EPS of $0.34 Double-Digit Global Growth for JANUVIA, JANUMET, SINGULAIR, REMICADE, NASONEX and ISENTRESS; Key Product Launches Underway...
-
Merck Guides FY 2011 EPS $3.66-3.76 vs. $3.69 Est. (MRK)
Friday, April 29, 2011 - 7:08am | 17Merck (NYSE: MRK) Guides FY 2011 EPS $3.66-3.76 vs. $3.69 Est.
-
Merck Reports EPS of $0.92 vs. $0.84 Estimate; Revenues $11.58B vs. $11.37B Estimate
Friday, April 29, 2011 - 7:04am | 21Merck (NYSE: MRK) Reports EPS of $0.92 vs. $0.84 Estimate; Revenues $11.58B vs. $11.37B Estimate.
-
US Stock Futures Mixed As Investors Await Economic Data, Earnings Reports; Research In Motion Shares Decline In Pre-Market trading
Friday, April 29, 2011 - 6:21am | 512US stock futures are mixed this morning as investors are awaiting economic reports and corporate results. Futures on the Dow Jones Industrial Average fell 4 points to 12,704.00 and S&P 500 index futures dropped 0.40 point to 1,354.50. Futures on the Nasdaq 100 rose 0.50 point to 2,402.25. On...
-
Top 4 Small-Cap Stocks In The Drug Related Products Industry With The Highest Cash (AUXL, PBH, CSKI, WNI)
Friday, April 29, 2011 - 3:28am | 135Below are the top small-cap drug related products stocks on the NYSE and the NASDAQ in terms of cash. Auxilium Pharmaceuticals Inc (NASDAQ: AUXL) had $128.21 million in total cash and no debt for the latest quarter. Prestige Brand Holdings Inc (NYSE: PBH) had $83.27 million in total cash and $...
-
Earnings Scheduled For April 29 (WY, AXL, NWL, ITT, MRK, PBI, MI, CPN, GT, CAT, AGP, NEE, CVX, PPC, DHI, ETR, VFC)
Friday, April 29, 2011 - 2:35am | 458Weyerhauser Co (NYSE: WY) is expected to report its Q1 EPS at $0.15 on revenue of $ 1.66 billion. American Axle & Manufacturing Holdings Inc (NYSE: AXL) is expected to post its Q1 earnings at $0.38 per share on revenue of $593.91 million. Newell Rubbermaid Inc (NYSE: NWL) is estimated to...
-
Stocks To Watch For April 29 (CVX, RIMM, CAT, MSFT, MRK)
Friday, April 29, 2011 - 2:07am | 276Some of the stocks that may grab investor focus today are: Wall Street expects Chevron Corp (NYSE: CVX) to report its Q1 EPS at $3.04 on revenue of $66.62 billion. CVX shares gained 0.08% to $108.90 in after-hours trading. Research In Motion Ltd (NASDAQ: RIMM) cut its Q1 profit projections, due...
-
Some Bullish Setups for Friday
Thursday, April 28, 2011 - 5:39pm | 1445( click to enlarge ) Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) made a new 52 week high today closing at $10.36 on heavy volume. The stock hit a high of $10.50, which is now resistance for Friday's continuation move. If the stock can break through resistance, we should see...
-
Endo Pharma Reports EPS of $1.00 vs. $1.00 Estimate; Revenues $564.6M vs. $564.63M Estimate (ENDP)
Thursday, April 28, 2011 - 4:11pm | 22Endo Pharma (NASDAQ: ENDP) Reports EPS of $1.00 vs. $1.00 Estimate; Revenues $564.6M vs. $564.63M Estimate
-
FDA Clears J&J's Abiraterone Acetate for Prostate Cancer -Bloomberg (JNJ)
Thursday, April 28, 2011 - 2:26pm | 24Bloomberg reports that the FDA has cleared J&J's (NYSE: JNJ) Abiraterone Acetate for prostate cancer.
-
Q&A With Stephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc. Discussing BioSante's Pipeline into 2012
Thursday, April 28, 2011 - 11:05am | 1252Point Roberts WA, LINCOLNSHIRE, Ill. April 28, 2011 - (Investorideas.com newswire.com) Investorideas.com, an investor research portal covering leading sectors including biotech stocks and pharma stocks, features an exclusive Q&A interview with Mr. Stephen M. Simes, President and Chief Executive...
-
EU Says Cephalon and Teva May Have Hindered Sales of their Generic Drug, EU will Probe Deal (CEPH, TEVA)
Thursday, April 28, 2011 - 11:03am | 33EU says Cephalon (NASDAQ: CEPH) and Teva (NASDAQ: TEVA) may have hindered sales of their generic drug.
-
Johnson & Johnson Announces Dividend Increase of 5.6% to $0.57
Thursday, April 28, 2011 - 10:43am | 50Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 5.6% increase in the quarterly dividend rate, from $0.54 per share to $0.57 per share. The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, NJ.